المؤلفون: Tracy BM; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio., Hoover E; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio., Jones N; Department of Surgery, Morehouse School of Medicine at Grady Memorial Hospital, Atlanta, Georgia., Hinrichs MJ; Department of Rehabilitation Medicine, Emory University School of Medicine at Grady Memorial Hospital, Atlanta, Georgia., Gelbard RB; Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.

المصدر: Topics in spinal cord injury rehabilitation [Top Spinal Cord Inj Rehabil] 2022 Fall; Vol. 28 (4), pp. 76-83. Date of Electronic Publication: 2022 Apr 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Spinal Injury Association Country of Publication: United States NLM ID: 9515174 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-5763 (Electronic) Linking ISSN: 10820744 NLM ISO Abbreviation: Top Spinal Cord Inj Rehabil Subsets: MEDLINE

مواضيع طبية MeSH: Trauma Centers* , Spinal Cord Injuries*, Humans ; Male ; Adult ; Female ; Retrospective Studies ; Injury Severity Score ; Patient Discharge

المؤلفون: Tracy BM; Department of Surgery, Division of Trauma, Critical Care, Burn, The Ohio State University Wexner Medical Center; Columbus, Ohio, USA., Victor M; Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health; Atlanta, Georgia, USA., Smith RN; Department of Behavioral, Social, and Health Education Sciences, Emory University Rollins School of Public Health; Atlanta, Georgia, USA.; Department of Surgery, Division of Acute Care Surgery at Grady Memorial Hospital; Atlanta, Emory University School of Medicine, Georgia, USA., Hinrichs MJ; Department of Rehabilitation Medicine at Grady Memorial Hospital; Atlanta, Emory University School of Medicine, Georgia, USA., Gelbard RB; Department of Surgery, Division of Acute Care Surgery; Birmingham, University of Alabama at Birmingham, AL, USA.

المصدر: Brain injury [Brain Inj] 2022 Jan 02; Vol. 36 (1), pp. 52-58. Date of Electronic Publication: 2022 Feb 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8710358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1362-301X (Electronic) Linking ISSN: 02699052 NLM ISO Abbreviation: Brain Inj Subsets: MEDLINE

مواضيع طبية MeSH: Brain Injuries*/rehabilitation , Brain Injuries, Traumatic*, Cohort Studies ; Humans ; Length of Stay ; Patient Discharge ; Retrospective Studies

المؤلفون: Corkill DJ; Research and Early Development, Respiratory & Immunology (R&I), AstraZeneca, Cambridge, U.K., Hunt AN; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, U.K., Hinrichs MJ; Biologics Safety Assessment, AstraZeneca, Gaithersburg, MD, U.S.A., White N; Bioanalytical Sciences, AstraZeneca, Cambridge, U.K., Rebelatto M; Biologics Safety Assessment, AstraZeneca, Gaithersburg, MD, U.S.A., Roskos L; Biologics Safety Assessment, AstraZeneca, Gaithersburg, MD, U.S.A., Nys J; Research and Early Development, Respiratory & Immunology (R&I), AstraZeneca, Cambridge, U.K., Scott A; Biologics Safety Assessment, AstraZeneca, Cambridge, U.K., Robinson MJ; Research and Early Development, Respiratory & Immunology (R&I), AstraZeneca, Cambridge, U.K., Ryan P; Biologics Safety Assessment, AstraZeneca, Gaithersburg, MD, U.S.A., Postle AD; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, U.K., Sleeman MA; Research and Early Development, Respiratory & Immunology (R&I), AstraZeneca, Cambridge, U.K.

المصدر: Clinical science (London, England : 1979) [Clin Sci (Lond)] 2021 Nov 26; Vol. 135 (22), pp. 2559-2573.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Portland Press on behalf of the Medical Research Society and the Biochemical Society Country of Publication: England NLM ID: 7905731 Publication Model: Print Cited Medium: Internet ISSN: 1470-8736 (Electronic) Linking ISSN: 01435221 NLM ISO Abbreviation: Clin Sci (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Arthritis, Rheumatoid/*metabolism , COVID-19/*therapy , Pulmonary Alveolar Proteinosis/*immunology , Pulmonary Surfactants/*metabolism , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*antagonists & inhibitors , Receptors, Granulocyte-Macrophage Colony-Stimulating Factor/*metabolism, Animals ; Antibodies, Monoclonal, Humanized/pharmacology ; Arthritis, Rheumatoid/therapy ; Autoantibodies/chemistry ; Bronchoalveolar Lavage Fluid ; COVID-19/immunology ; Choline/analogs & derivatives ; Female ; Granulocyte-Macrophage Colony-Stimulating Factor/chemistry ; Inflammation ; Interleukin-6/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Phenotype ; Pulmonary Alveolar Proteinosis/genetics ; SARS-CoV-2/immunology ; Surface-Active Agents

المؤلفون: de Bono JS; Institute of Cancer Research, Surrey, United Kingdom. debono@icr.ac.uk., Fleming MT; Virginia Oncology Associates, Norfolk, Virginia., Wang JS; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida., Cathomas R; Kantonsspital Graubünden, Chur, Switzerland., Miralles MS; AstraZeneca, Gaithersburg, Maryland., Bothos J; AstraZeneca, Gaithersburg, Maryland., Hinrichs MJ; AstraZeneca, Gaithersburg, Maryland., Zhang Q; AstraZeneca, Gaithersburg, Maryland., He P; AstraZeneca, Gaithersburg, Maryland., Williams M; AstraZeneca, Gaithersburg, Maryland., Rosenbaum AI; AstraZeneca, South San Francisco, California., Liang M; AstraZeneca, South San Francisco, California., Vashisht K; AstraZeneca, Gaithersburg, Maryland., Cho S; AstraZeneca, Gaithersburg, Maryland., Martinez P; AstraZeneca, Gaithersburg, Maryland., Petrylak DP; Yale Comprehensive Cancer Center, New Haven, Connecticut.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jul 01; Vol. 27 (13), pp. 3602-3609. Date of Electronic Publication: 2021 Apr 01.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Immunoconjugates*/pharmacology , Immunoconjugates*/therapeutic use , Prostatic Neoplasms, Castration-Resistant*/drug therapy , Prostatic Neoplasms, Castration-Resistant*/pathology, Aged ; Aged, 80 and over ; Humans ; Male ; Middle Aged ; Androstenes/therapeutic use ; Antigens, Surface ; Benzamides/therapeutic use ; Glutamate Carboxypeptidase II/antagonists & inhibitors ; Neoplasm Metastasis ; Nitriles/therapeutic use ; Phenylthiohydantoin/therapeutic use ; Treatment Failure

المؤلفون: Xia L; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA; Department of Hematology & Oncology, The Third Affiliated Hospital of Anhui Medical University, Hefei 230032, China., Wen L; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Qin Y; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Dobson HE; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA., Zhang T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China., Comer FI; AstraZeneca, Gaithersburg, MD, USA., Hinrichs MJ; AstraZeneca, Gaithersburg, MD, USA., Oberst MD; AstraZeneca, Gaithersburg, MD, USA., Coats SR; AstraZeneca, Gaithersburg, MD, USA., Chang AE; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA., Liu Y; Department of Hematology & Oncology, The Third Affiliated Hospital of Anhui Medical University, Hefei 230032, China., Bao Y; Department of Hematology & Oncology, The Third Affiliated Hospital of Anhui Medical University, Hefei 230032, China., Dai F; Department of Hematology & Oncology, The Third Affiliated Hospital of Anhui Medical University, Hefei 230032, China., Wicha MS; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA. Electronic address: mwicha@umich.edu., Li Q; University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA. Electronic address: qiaoli@umich.edu.

المصدر: Cell chemical biology [Cell Chem Biol] 2021 May 20; Vol. 28 (5), pp. 610-624.e5. Date of Electronic Publication: 2021 Mar 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101676030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2451-9448 (Electronic) Linking ISSN: 24519448 NLM ISO Abbreviation: Cell Chem Biol Subsets: MEDLINE

مواضيع طبية MeSH: Immunoconjugates/*pharmacology , Neoplastic Stem Cells/*drug effects , Receptor, ErbB-2/*antagonists & inhibitors, Animals ; Cell Line, Tumor ; Female ; Humans ; Immunoconjugates/chemistry ; Mice ; Mice, Inbred BALB C ; Neoplastic Stem Cells/immunology ; Receptor, ErbB-2/immunology

المؤلفون: Williams M; Translational Medicine, Oncology, AstraZeneca, Gaithersburg, Maryland., Spreafico A; Drug Development Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Vashisht K; AstraZeneca, Gaithersburg, Maryland., Hinrichs MJ; Early Development Oncology, Ipsen LLC, Cambridge, Massachusetts. mary.jane.hinrichs@ipsen.com.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Sep; Vol. 19 (9), pp. 1770-1783. Date of Electronic Publication: 2020 Jun 16.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Gene Regulatory Networks*/drug effects, Antineoplastic Agents/*therapeutic use , Immunoconjugates/*therapeutic use , Neoplasms/*drug therapy, Antineoplastic Agents/pharmacology ; Clinical Trials as Topic ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Immunoconjugates/pharmacology ; Intention to Treat Analysis ; Molecular Targeted Therapy ; Neoplasms/genetics ; Patient Selection

المؤلفون: Li JY, Perry SR, Muniz-Medina V, Wang X, Wetzel LK, Rebelatto MC, Masson Hinrichs MJ, Bezabeh BZ, Fleming RL, Dimasi N, Feng H, Toader D, Yuan AQ, Xu L, Lin J, Gao C, Wu H, Dixit R, Osbourn JK, Coats SR

المصدر: Cancer cell [Cancer Cell] 2019 Jun 10; Vol. 35 (6), pp. 948-949.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: PubMed not MEDLINE

المؤلفون: White JB; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA., Fleming R; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA., Masterson L; b Spirogen Ltd , QMB Innovation Center , London , UK., Ruddle BT; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA., Zhong H; c Oncology Research , MedImmune , Gaithersburg , MD , USA., Fazenbaker C; c Oncology Research , MedImmune , Gaithersburg , MD , USA., Strout P; c Oncology Research , MedImmune , Gaithersburg , MD , USA., Rosenthal K; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA., Reed M; d Biologics Safety Assessment , MedImmune , Gaithersburg , MD , USA., Muniz-Medina V; e Biosuperiors , MedImmune , Gaithersburg , MD , USA., Howard P; b Spirogen Ltd , QMB Innovation Center , London , UK., Dixit R; d Biologics Safety Assessment , MedImmune , Gaithersburg , MD , USA., Wu H; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA., Hinrichs MJ; d Biologics Safety Assessment , MedImmune , Gaithersburg , MD , USA., Gao C; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA., Dimasi N; a Antibody Discovery and Protein Engineering , MedImmune , Gaithersburg , MD , USA.

المصدر: MAbs [MAbs] 2019 Apr; Vol. 11 (3), pp. 500-515. Date of Electronic Publication: 2019 Mar 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs

مواضيع طبية MeSH: Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacology , Immunoconjugates*/chemistry , Immunoconjugates*/pharmacology , Trastuzumab*/chemistry , Trastuzumab*/pharmacology, Benzodiazepines/*chemistry , Pyrroles/*chemistry , Receptor, ErbB-2/*antagonists & inhibitors , Stomach Neoplasms/*drug therapy, Animals ; Female ; Humans ; MCF-7 Cells ; Mice, Nude ; Rats ; Receptor, ErbB-2/metabolism ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology ; Xenograft Model Antitumor Assays

المؤلفون: Chen B; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA Chenb@medimmune.com SimsG@MedImmune.com., Vousden KA; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Naiman B; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Turman S; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Sun H; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Wang S; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA.; Viela Bio, Gaithersburg, Maryland, USA., Vinall LMK; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Kemp BP; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Kasturiangan S; Department of Antibody Discovery and Protein Engineering, MedImmune LLC, Gaithersburg, Maryland, USA., Rees DG; Department of Antibody Discovery and Protein Engineering, MedImmune Ltd, Granta Park, Great Abington, UK., Grant E; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Hinrichs MJ; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Eck S; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., DiGiandomenico A; Microbial Sciences, MedImmune, LLC, Gaithersburg, Maryland, USA., Jack Borrok M; Department of Antibody Discovery and Protein Engineering, MedImmune LLC, Gaithersburg, Maryland, USA., Ly N; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Xiong X; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Gonzalez C; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Morehouse C; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Wang Y; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Zhou Y; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Cann J; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Zhao W; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Koelkebeck H; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Okubo K; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Mayadas TN; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Howe D; Department of Clinical Development, MedImmune Ltd, Granta Park, Great Abington, UK., Griffiths J; Department of Translational Medicine, MedImmune LLC, Gaithersburg, Maryland, USA., Kolbeck R; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Herbst R; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA., Sims GP; Department of Respiratory, Inflammation and Autoimmunity, MedImmune LLC, Gaithersburg, Maryland, USA Chenb@medimmune.com SimsG@MedImmune.com.

المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2019 Feb; Vol. 78 (2), pp. 228-237. Date of Electronic Publication: 2018 Nov 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Anti-Idiotypic/*pharmacology , Antigen-Antibody Complex/*drug effects , Autoimmune Diseases/*drug therapy , Immunologic Factors/*pharmacology , Receptors, IgG/*immunology, Animals ; Antibodies, Antineutrophil Cytoplasmic/immunology ; Antigen-Antibody Complex/immunology ; Autoimmune Diseases/immunology ; Dendritic Cells/immunology ; Humans ; Immunoglobulin G/immunology ; Interleukin-6/immunology ; Macaca fascicularis ; Mice ; Mice, Transgenic ; Neutrophils/immunology ; Reactive Oxygen Species/immunology ; Tumor Necrosis Factor-alpha/immunology

المؤلفون: Cho S; MedImmune, Gaithersburg, Maryland. chos@medimmune.com francesca.zammarchi@adctherapeutics.com., Zammarchi F; ADC Therapeutics (UK) Limited, London, United Kingdom. chos@medimmune.com francesca.zammarchi@adctherapeutics.com., Williams DG; Spirogen, London, United Kingdom., Havenith CEG; ADC Therapeutics (UK) Limited, London, United Kingdom., Monks NR; MedImmune, Gaithersburg, Maryland., Tyrer P; Spirogen, London, United Kingdom., D'Hooge F; Spirogen, London, United Kingdom., Fleming R; MedImmune, Gaithersburg, Maryland., Vashisht K; MedImmune, Gaithersburg, Maryland., Dimasi N; MedImmune, Gaithersburg, Maryland., Bertelli F; Spirogen, London, United Kingdom., Corbett S; Spirogen, London, United Kingdom.; University College London, London, United Kingdom., Adams L; Spirogen, London, United Kingdom., Reinert HW; University College London, London, United Kingdom., Dissanayake S; ADC Therapeutics (UK) Limited, London, United Kingdom., Britten CE; ADC Therapeutics (UK) Limited, London, United Kingdom., King W; MedImmune, Gaithersburg, Maryland., Dacosta K; MedImmune, Gaithersburg, Maryland., Tammali R; MedImmune, Gaithersburg, Maryland., Schifferli K; MedImmune, Gaithersburg, Maryland., Strout P; MedImmune, Gaithersburg, Maryland., Korade M 3rd; MedImmune, Gaithersburg, Maryland., Masson Hinrichs MJ; MedImmune, Gaithersburg, Maryland., Chivers S; ADC Therapeutics (UK) Limited, London, United Kingdom., Corey E; University of Washington, Seattle, Washington., Liu H; Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York., Kim S; Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York., Bander NH; Department of Urology, Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York., Howard PW; Spirogen, London, United Kingdom., Hartley JA; Spirogen, London, United Kingdom.; University College London, London, United Kingdom., Coats S; MedImmune, Gaithersburg, Maryland., Tice DA; MedImmune, Gaithersburg, Maryland., Herbst R; MedImmune, Gaithersburg, Maryland., van Berkel PH; ADC Therapeutics (UK) Limited, London, United Kingdom.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2018 Oct; Vol. 17 (10), pp. 2176-2186. Date of Electronic Publication: 2018 Jul 31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*pharmacology , Biomarkers, Tumor/*antagonists & inhibitors , Glutamate Carboxypeptidase II/*antagonists & inhibitors , Immunoconjugates/*pharmacology , Prostatic Neoplasms/*drug therapy , Prostatic Neoplasms/*immunology, Animals ; Antigens, Surface/genetics ; Antigens, Surface/metabolism ; Cell Line, Tumor ; Cross Reactions/immunology ; Disease Models, Animal ; Drug Evaluation, Preclinical ; Gene Expression ; Glutamate Carboxypeptidase II/genetics ; Glutamate Carboxypeptidase II/metabolism ; Humans ; Immunohistochemistry ; Macaca fascicularis ; Male ; Mice ; Prostatic Neoplasms/pathology ; Xenograft Model Antitumor Assays